Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Prior Bioprosthetic Valve Replacement or Valve Repair: Insights from the ARISTOTLE Trial

Patrícia O. Guimarães,Sean D. Pokorney,Renato D. Lopes,Daniel Wojdyla,Bernard J. Gersh,Anna Giczewska,Anthony P. Carnicelli,Basil S. Lewis,Michael Hanna,Lars Wallentin,Dragos Vinereanu,John H. Alexander,Christopher B. Granger

Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Prior Bioprosthetic Valve Replacement or Valve Repair: Insights from the ARISTOTLE Trial

2019

Patrícia O. Guimarães
Sean D. Pokorney
Renato D. Lopes
Daniel Wojdyla
Bernard J. Gersh
Anna Giczewska
Anthony P. Carnicelli
Basil S. Lewis
Michael Hanna
Lars Wallentin
Dragos Vinereanu
John H. Alexander
Christopher B. Granger

Background The optimal anticoagulation strategy for patients with atrial fibrillation (AF) and bioprosthetic valve (BPV) replacement or native valve repair remains uncertain.HypothesisWe evaluated ...

Keywords:

Atrial fibrillation
Diabetes mellitus
Valve replacement
Internal medicine
Cardiology
Apixaban
Medicine
Warfarin
Proportional hazards model
Randomized controlled trial
Stroke
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations